← Eichor
Condition: Penile Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Penile Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT05899361At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma
Phase N/A · 1 location(s) · Oslo University Hospital · NCT05447273Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161532Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · 582 location(s) · National Cancer Institute (NCI) · NCT03866382A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial
Phase 1 · 12 location(s) · EvolveImmune United, Inc · NCT07217171International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Phase 3 · 17 location(s) · Institute of Cancer Research, United Kingdom · NCT02305654SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Phase 1 · 1 location(s) · The Affiliated Hospital of Qingdao University · NCT06544720MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinom
Phase 1 · 1 location(s) · Jiyan Liu · NCT07054307DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced
Phase 2 · 8 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07110038E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Phase 1/Phase 2 · 2 location(s) · Christian Hinrichs · NCT05639972Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanc
Phase 2 · 1 location(s) · Fudan University · NCT06684327Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
Phase 2 · 2 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT05526989HRYZ-T101 Injection for HPV18 Positive Solid Tumor
Phase 1 · 1 location(s) · HRYZ Biotech Co. · NCT05952947Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · 1 location(s) · Fudan University · NCT06683846QL1706 Plus Lenvatinib in Previously Treated Penile Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07384416Lymphedema After Urologic Surgery
Phase N/A · 2 location(s) · Vastra Gotaland Region · NCT05264337Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genit
Phase 3 · 2 location(s) · Regina Elena Cancer Institute · NCT06717711DEfeating PEnile CAncer-2
NA · 9 location(s) · University Hospital Tuebingen · NCT07378670TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06415318EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Can
Phase 2 · 1 location(s) · Jiyan Liu · NCT07518979Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
Phase 2 · 2 location(s) · The Netherlands Cancer Institute · NCT06353906Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
Phase 2 · 3 location(s) · Mayo Clinic · NCT06104618E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04923178Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer
Phase 1 · 1 location(s) · German Cancer Research Center · NCT05999396
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.